Valente Manuela 4

What Happened

• Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold a total of 4,973 shares in two open‑market transactions. She sold 2,597 shares on 2026-04-06 at an average reported price of $4.85 for $12,583, and 2,376 shares on 2026-04-07 at an average reported price of $4.87 for $11,566. Total proceeds were approximately $24,149.
• These were sales (not purchases) and were executed to satisfy tax withholding obligations related to recently vested restricted stock units — a routine, non‑market‑timing action rather than a discretionary bet on the stock.

Key Details

• Transaction dates & reported prices: 2026-04-06 — 2,597 shares @ $4.85 (proceeds $12,583); 2026-04-07 — 2,376 shares @ $4.87 (proceeds $11,566).
• Total shares sold: 4,973; total proceeds: ≈ $24,149.
• Footnote F1: Sales were to satisfy tax withholding for RSUs vested on April 2 and 3, 2026.
• Footnote F2: Reported prices are weighted averages; individual trades ranged from $4.68 to $5.01. Detailed per‑trade prices can be provided on request.
• Trading plan / intent: Sales were effected under a pre‑established Rule 10b5‑1 plan and were not discretionary.
• Filing: Form 4 was filed 2026-04-08 for transactions on 2026-04-06 and 2026-04-07 — appears timely under the two‑business‑day requirement.
• Shares owned after the transaction: not specified in the information provided in this summary.

Context

• These sales were tax‑withholding related and executed under a 10b5‑1 plan, which typically indicates routine administration of equity awards rather than an insider expressing a positive or negative view on the company.